J9046 HCPCS Level II code: Injection, bortezomib (dr. reddy's), not therapeutically equivalent to j9041, 0.1 mg

J9046 is the HCPCS code for “Injection, bortezomib (dr. reddy's), not therapeutically equivalent to j9041, 0.1 mg” in CMS’s October 2026 release, in effect from Oct 1, 2026.

Official description

J9046

Injection, bortezomib (dr. reddy's), not therapeutically equivalent to j9041, 0.1 mg

Short description: Inj, bortezomib, dr. reddy's

HCPCS · United States

Medicare details

The indicators CMS publishes with J9046 in its October 2026 file. They describe Medicare’s handling, not another payer’s.

Medicare coverage
Carrier judgment
Medicare pricing
Drugs
ASC
Approved for ambulatory surgical centers
Type of service
Medical care
BETOS category
Chemotherapy
Added
Jan 1, 2023

Where J9046 sits

  1. 1J codesDrugs administered other than orally
  2. 2Active code J9046Injection, bortezomib (dr. reddy's), not therapeutically equivalent to j9041, 0.1 mg

Source and release

Data release
HCPCS Level II · October 2026
Effective date
Oct 1, 2026
Publisher
CMS

This page is built from the HCPCS Level II catalog that Vero Codes reads when it suggests codes: Centers for Medicare & Medicaid Services’s October 2026 release, imported from the publisher’s file and checked against it. The description, notes and structured data come from the same record.

Frequently asked questions

What does HCPCS code J9046 mean?

J9046 is the HCPCS code for “Injection, bortezomib (dr. reddy's), not therapeutically equivalent to j9041, 0.1 mg” in CMS’s HCPCS Level II October 2026 release.

Does Medicare cover J9046?

CMS lists J9046’s Medicare coverage as “Carrier judgment” and its pricing as “Drugs”. Coverage and payment still depend on the patient, the setting, the documentation and the payer.

Which HCPCS Level II release does this page use?

It uses CMS’s October 2026 release, in effect from Oct 1, 2026 to Dec 31, 2026. It is a reference: confirm the code against the current list and the payer’s rules before you submit it.